venlafaxine hydrochloride

Generic: venlafaxine hydrochloride

Labeler: zydus pharmaceuticals usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name venlafaxine hydrochloride
Generic Name venlafaxine hydrochloride
Labeler zydus pharmaceuticals usa inc.
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

venlafaxine hydrochloride 150 mg/1

Manufacturer
Zydus Pharmaceuticals USA Inc.

Identifiers & Regulatory

Product NDC 68382-036
Product ID 68382-036_8c02c121-fe14-45f5-b2bc-b09fd377531f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090174
Listing Expiration 2026-12-31
Marketing Start 2011-06-01

Pharmacologic Class

Classes
norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68382036
Hyphenated Format 68382-036

Supplemental Identifiers

RxCUI
313581 313583 313585
UPC
0368382034106 0368382035103 0368382036100
UNII
7D7RX5A8MO

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name venlafaxine hydrochloride (source: ndc)
Generic Name venlafaxine hydrochloride (source: ndc)
Application Number ANDA090174 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-06)
  • 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-10)
  • 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-16)
source: ndc

Packages (3)

68382-036-06 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-06) 68382-036-10 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-10) 68382-036-16 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-16)

Ingredients (1)

venlafaxine hydrochloride (150 mg/1)

Linked Drug Pages (1)

venlafaxine hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8c02c121-fe14-45f5-b2bc-b09fd377531f", "openfda": {"upc": ["0368382034106", "0368382035103", "0368382036100"], "unii": ["7D7RX5A8MO"], "rxcui": ["313581", "313583", "313585"], "spl_set_id": ["5351fe67-17d9-42ec-9e8b-6585fdb9e29e"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-06)", "package_ndc": "68382-036-06", "marketing_start_date": "20110601"}, {"sample": false, "description": "1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-10)", "package_ndc": "68382-036-10", "marketing_start_date": "20110601"}, {"sample": false, "description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68382-036-16)", "package_ndc": "68382-036-16", "marketing_start_date": "20110601"}], "brand_name": "venlafaxine hydrochloride", "product_id": "68382-036_8c02c121-fe14-45f5-b2bc-b09fd377531f", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "68382-036", "generic_name": "venlafaxine hydrochloride", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "venlafaxine hydrochloride", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA090174", "marketing_category": "ANDA", "marketing_start_date": "20110601", "listing_expiration_date": "20261231"}